Abstract
Background
The understanding of biology of well-differentiated thyroid cancer has improved in the last two decades with the detailed understanding of prognostic factors and risk group stratification. The risk groups are crucial in the management of thyroid cancer and overall prognosis.
TNM Staging System
The TNM staging system has been used in all human cancers, and it adheres to the biology of tumors. The data in thyroid cancer comes from retrospective studies, as there are no prospective randomized trials. The most recent TNM staging system was revised and published (6th edition) in 2002. The major attributes of the staging system include: age as the most important prognostic factor, and age is included in the staging system, below and above the age of 45; T1 tumors are considered to be those below 2 cm; T3 tumors include minor extrathyroidal extension invading the strap muscles; T4 tumors includes T4a and T4b, T4a being operable tumors; all anaplastic cancers are T4, although operable anaplastic thyroid cancers are considered to be T4a.
Conclusion
These changes in the TNM system are consistent with our current philosophy in the overall management of thyroid cancer and adjuvant therapy. The N staging system includes N1a and N1b—N1a being level VI lymph nodes, while N1b includes level IV and superior mediastinal and contralateral neck nodes. The TNM staging system helps reporting our data and comparing results in different parts of the world. However, there is no level I evidence in thyroid cancer.
Similar content being viewed by others
REFERENCES
Denoix PF. Tumor, Node and Metastasis (TNM). Bull Inst Nat Hyg (Paris) 1944;1:69
Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol 2003;21:3–7
Gospodaroqicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification. Cancer 2004;100:1–5
In: Greene FL, Compton CC, Fritz AG, Shah JP, Winchester DP (2006) AJCC Cancer Staging Atlas Springer New York
Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid—a matched pair analysis. Head Neck 1996;18:127–132
Sugitani I, Kasai N, Fujimoto Y, et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135(2):139–148
Shaha AR. Controversies in the management of thyroid nodule. Laryngoscope 2000;110(2 Pt 1):183–193
Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer 1998;83:2638–2648
Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088–1095
Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:947–953
Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995;118:1131–1138
Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033–1041
Cady B. Our AMES is true: how an old concept still hits the mark, or risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997;174:462–468
Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–953
Pasieka JL, Zedenius J, Auer G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992;112:1154–1160
Schindler A, et al. Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68:324–330
Simpson WJ, et al. Papillary and follicular thyroid cancer: prognostic factors in 1578 patients. Am J Med 1987;83:479–488
Tubiana M, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804
Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 1997;4:328–333
Clark OH. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982;196:361–370
Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 1992;164:671–676
Shah JP, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658–661
Cunningham MP, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;16:344–347
Noguchi M, et al. Multivariate study of prognostic factors of differentiated thyroid carcinoma: The significance of histologic subtype. Int Surg 1993;78:10–15
Mazzaferri EL, Jhiang SM. Long-term of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418–428
Mazzaferri EL. Review. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14:315–332
Cady B. Staging in thyroid carcinoma. Cancer 1998;83:844–847
Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998;83:1012–1021
Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program, 1973–1991. Cancer 1997;79:564–573
Anderson PE, et al. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 1995;170:467–470
Czaja JM, McCaffrey TV. The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:484–490
Grillo HC, Zannini P. Resectional management of airway invasion by thyroid carcinoma. Ann Thorac Surg 1986;42:287–298
McCaffrey TV, Bergstralh EJ, Hay ID. Locally invasive papillary thyroid carcinoma:1940–1990. Head Neck 1994;16:165–172
Passler C, Scheuba C, Asari R, et al. Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 2005;92(2):184–189
Machens A, Holzhausen HJ, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 2005;103(11):2269–2273
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shaha, A.R. TNM Classification of Thyroid Carcinoma. World J Surg 31, 879–887 (2007). https://doi.org/10.1007/s00268-006-0864-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-006-0864-0